T-lymphocyte micronuclei dose response from prostate radiotherapy.

Area of Science:

• Oncology
• Radiation Biology
• Immunology

Background:

• Pelvic radiotherapy for prostate cancer can cause systemic toxicity.
• Monitoring radiation dose effects on the immune system is crucial for patient management.

Purpose of the Study:

• To establish a dose-response relationship for micronuclei production in T-lymphocytes after pelvic radiotherapy.
• To explore the utility of lymphocyte micronuclei as a biological dosimeter for prostate cancer treatment.

Main Methods:

• Analyzing micronuclei (MN) production in peripheral blood T-lymphocytes.
• Correlating MN frequency with the integral radiation dose delivered to the prostate/pelvic area in patients undergoing radiotherapy.

Main Results:

• A linear, in vivo, clinical dose-response relationship was observed between radiation dose and MN production.
• Increased radiation dose directly correlated with increased MN frequency in T-lymphocytes.

Conclusions:

• The lymphocyte micronuclei assay serves as a valid biological dosimetry system for pelvic radiotherapy.
• This assay can inform treatment planning, encouraging conformal radiotherapy to minimize immune system toxicity.